SEC Form 4 Reporting Owner · CIK 0001952920

Greg Pyszczymuka

Officer at Aytu Biopharma Inc · Director at Evoke Pharma Inc

Bought (12 mo) —
Sold (12 mo) —
Form 4 Filings 18
Companies 2
Filing Activity 2026-07-30 first filed 2022-12-21

Trading record

Open-market buys +$46.9K 2 filings
Open-market sales — 0 filings
Sales under a 10b5-1 plan — No open-market sales

Companies

Open-market shares bought and sold at each company, and the holding after the latest filing
CompanyRoleFilingsBoughtSoldNetHolding after latest filing
AYTUAytu BioPharma Insider tradingOfficer15112,000—+112,00056,102 2026-07-30
EVOKEvoke Pharma Insider tradingDirector3————

Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.

Insider Trading History

Company Type Value Filed View filing
AYTU Aytu Biopharma Inc Award — 2026-07-30
EVOK Evoke Pharma Inc - — 2025-12-17
AYTU Aytu Biopharma Inc Award — 2025-10-07
EVOK Evoke Pharma Inc Award — 2025-05-22
AYTU Aytu Biopharma Inc Exercise — 2025-03-31
EVOK Evoke Pharma Inc Award — 2025-02-24
AYTU Aytu Biopharma Inc Exercise — 2025-01-02
AYTU Aytu Biopharma Inc Award — 2024-11-08
AYTU Aytu Biopharma Inc Exercise — 2024-10-02
AYTU Aytu Biopharma Inc Exercise — 2024-07-02
AYTU Aytu Biopharma Inc Exercise — 2024-04-02
AYTU Aytu Biopharma Inc Exercise — 2024-01-02
AYTU Aytu Biopharma Inc Exercise — 2023-10-03
AYTU Aytu Biopharma Inc Award — 2023-08-15
AYTU Aytu Biopharma Inc Exercise — 2023-07-06
AYTU Aytu Biopharma Inc Buy +$22,428 2023-06-20
AYTU Aytu Biopharma Inc Exercise — 2023-06-20
AYTU Aytu Biopharma Inc Buy +$24,480 2022-12-21